ArticleIn vitro cellular & developmental biology. Animal2025
Overexpression of miR-20a targeting DUSP3 inhibits OCLN ubiquitination levels and alleviates sepsis induced intestinal barrier dysfunction.
Article in In vitro cellular & developmental biology. Animal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sepsis is a severe organ dysfunction syndrome caused by the host's dysfunctional response to infection. Sepsis can severely damage intestinal epithelial tissue, lead to intestinal barrier dysfunction, and seriously endanger human health. Therefore, this study aimed to explore the mechanism of miR-20a in sepsis-induced intestinal barrier dysfunction. In this study, mice and NCM460 cells were subjected to cecal ligation and puncture (CLP) and 1 μg/mL LPS, respectively, to establish a sepsis model. The expression of relevant genes, apoptosis, inflammation, and intestinal barrier dysfunction-related indices under the conditions of overexpression of miR-20a or DUSP3 and knockdown of DUSP3 or OCLN were assessed by western blotting, RT-qPCR, ELISA, flow cytometry, immunofluorescence, and HE staining. The experimental results revealed that in sepsis-induced intestinal barrier dysfunction, the expression of miR-20a and OCLN was downregulated, whereas that of DUSP3 was upregulated. Functionally, miR-20a inhibited LPS-induced intestinal epithelial cell apoptosis and inflammation and relieved sepsis-induced intestinal barrier dysfunction in mice. Experiments investigating the downstream mechanisms revealed that miR-20a overexpression suppressed LPS-induced intestinal epithelial cell apoptosis and inflammation and relieved sepsis-induced intestinal barrier dysfunction by targeting and inhibiting DUSP3 levels and OCLN ubiquitination. In conclusion, miR-20a relieves sepsis-induced intestinal barrier dysfunction by inhibiting DUSP3 and suppressing the ubiquitination of OCLN.
Indexed as
Identifiers
40392484What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.